PRVA
Undervalued by 56.6% based on the discounted cash flow analysis.
Market cap | $2.68 Billion |
---|---|
Enterprise Value | $2.22 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.12 |
Beta | 0.83 |
Outstanding Shares | 120,623,670 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 169.88 |
---|---|
PEG | 410.13 |
Price to Sales | 1.64 |
Price to Book Ratio | 4.6 |
Enterprise Value to Revenue | 1.23 |
Enterprise Value to EBIT | 96.04 |
Enterprise Value to Net Income | 142 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0.01 |
No data
No data
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for del...